Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Acquisitions: 2015-2025

  • Phibro Animal Health's Acquisitions was N/A to -$5.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.6 million, marking a year-over-year change of. This contributed to the annual value of $286.5 million for FY2025, which is 8630.32% up from last year.
  • Latest data reveals that Phibro Animal Health reported Acquisitions of -$5.3 million as of Q2 2025, which was down 607.98% from $1.1 million recorded in Q1 2025.
  • Phibro Animal Health's 5-year Acquisitions high stood at $2.7 million for Q2 2022, and its period low was -$5.3 million during Q2 2025.
  • In the last 2 years, Phibro Animal Health's Acquisitions had a median value of -$44,000 in 2024 and averaged -$1.4 million.
  • Data for Phibro Animal Health's Acquisitions shows a peak YoY skyrocketed of 2,493.18% (in 2025) over the last 5 years.
  • Phibro Animal Health's Acquisitions (Quarterly) stood at $2.7 million in 2022, then reached -$44,000 in 2024, then surged by 2,493.18% to -$5.3 million in 2025.
  • Its Acquisitions was -$5.3 million in Q2 2025, compared to $1.1 million in Q1 2025 and -$44,000 in Q1 2024.